Weekly Briefing No. 115 | Cryptoassets: Point and Shoot at Your Own Risk; Can Fintech Reduce Income Inequality?

Weekly Briefing No. 115 | Cryptoassets: Point and Shoot at Your Own Risk; Can Fintech Reduce Income Inequality?

Welcome to The FR’s 115th edition. Here’s what’s sizzling on our plate this week: Smile and enjoy the crypto-madness. Just be careful; Branko Milanović’s innovative ideas for reducing economic inequality; January’s heavy deal activity; Caribou Honig on pushy bots; UK’s open banking implementer; Aflac, MasterCard and Alexa rock CES; Company of Note: Nav; Follow-Ups & Corrections: We’re sorry, Mayor Lowry

Read More

Weekly Briefing No. 114 | A Blockchain Cure for Baldness and Spotify’s “Weird” Listing Plans

Weekly Briefing No. 114 | A Blockchain Cure for Baldness and Spotify’s “Weird” Listing Plans

Welcome to 2018 and bone-chilling cold that seems to have frozen everything but financial innovation. Here’s what warmed us up this week: Blockchain hype; Spotify’s disruptive/odd listing plans; Frank, Wealthfront and MoneyLion raise; Amazon’s HQ2’s talent vortex; State Street’s Kensho-based ETFs; A blow to cannabis banking; MoneyGram; Company of Note: Earny

Read More

Weekly Briefing No. 109 | A December to Remember: Zenefits’ CEO, Is Smart Beta Smart or Cheap? Earth’s Most Powerful Millennial

Weekly Briefing No. 109 | A December to Remember: Zenefits’ CEO, Is Smart Beta Smart or Cheap? Earth’s Most Powerful Millennial

Happy December. We’re ringing in the last month of the year with a fresh issue of The FR. This week: Zenefits boss Jay Fulcher sits down with The FR’s Gregg Schoenberg; Smart beta ETFs could be tricky, but they’re getting cheaper; The world’s most powerful Millennial needs financial innovation; Bitcoin’s omnipresence; Sam Altman’s latest UBI twist; Wells Fargo; Q4 deals; Company of Note: Little Rock’s VC FinTech Accelerator; Podcasts of Note: A lawsuit against Cambridge Analytica

Read More

Weekly Briefing No. 44 | A Fintech Opportunity in the EpiPen Fiasco?

Weekly Briefing No. 44 | A Fintech Opportunity in the EpiPen Fiasco?

As the summer winds fade, we look back at Mylan Labs’ EpiPen fiasco and ponder a possible fintech opportunity. We also take note of Apple’s nasty battle with Aussie banks, the resilience of some fallen unicorns, an ETF issuer’s reinvention as a fintech company, a blockchain non-problem and the end of a tech-bank celebrity marriage. Finally, we highlight Snagajob, a gig economy standout.

Read More